ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Bronchoscopic Imaging for Interstitial Lung Disease

CHEST 2022 Coverage

G. Zhi Cheng

Robotically-Assisted Bronchoscopic Transbronchial Lung Cryobiopsy (T…

Ismael Matus

Rapid Fire Journal Club 6 – SARCORT Trial (ERJ, 2023)

PulmPEEPs

D. Furfaro, L. Hedrick

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

Current and Evolving Paradigm of Anti-Inflammatory Therapy in Pulmon…

Temple Lung Center

R. Gupta

Interstitial Lung Disease: Multidisciplinary Discussion

UCLA Health

S. Sam Weigt, E. R. Volkmann, F. Abtin, M. Fishbein

Pulmonary Manifestations of SLE: An Update

Keck School of Medicine of USC

F. Quismorio

Review of Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-D…

Paolo Tarantino

Clinical Trials for Pulmonary Fibrotic Diseases

Temple Lung Center

G. Criner

Identifying the Signs and Symptoms of Progressive Pulmonary Fibrosis

The France Foundation

V. Khangoora